Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Equity Ratio: 2009-2025

Historic Equity Ratio for China Pharma Holdings (CPHI) over the last 17 years, with Sep 2025 value amounting to 0.53.

  • China Pharma Holdings' Equity Ratio rose 8.51% to 0.53 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.53, marking a year-over-year increase of 8.51%. This contributed to the annual value of 0.52 for FY2024, which is 14.98% up from last year.
  • According to the latest figures from Q3 2025, China Pharma Holdings' Equity Ratio is 0.53, which was up 12.07% from 0.47 recorded in Q2 2025.
  • Over the past 5 years, China Pharma Holdings' Equity Ratio peaked at 0.53 during Q3 2025, and registered a low of 0.17 during Q3 2022.
  • Moreover, its 3-year median value for Equity Ratio was 0.48 (2024), whereas its average is 0.45.
  • In the last 5 years, China Pharma Holdings' Equity Ratio plummeted by 53.59% in 2022 and then spiked by 127.51% in 2023.
  • Quarterly analysis of 5 years shows China Pharma Holdings' Equity Ratio stood at 0.27 in 2021, then declined by 9.21% to 0.24 in 2022, then surged by 87.64% to 0.45 in 2023, then increased by 14.98% to 0.52 in 2024, then climbed by 8.51% to 0.53 in 2025.
  • Its Equity Ratio stands at 0.53 for Q3 2025, versus 0.47 for Q2 2025 and 0.49 for Q1 2025.